Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)Jacques Bernier, Jean Louis Lefèbvre, Thomas F. Pajak et al.|Head & Neck|2005Cited by 1.8k
Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trialM. Bolla, M. Piérart, J Rafael Pfeffer et al.|The Lancet|2002Cited by 1.7k
Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and GoserelinM. Bolla, M. Piérart, Dionisio González et al.|New England Journal of Medicine|1997Cited by 1.6k
External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised studyM. Bolla, Laurence Collette, Geertjan van Tienhoven et al.|The Lancet Oncology|2010Cited by 944
Critical Impact of Radiotherapy Protocol Compliance and Quality in the Treatment of Advanced Head and Neck Cancer: Results From TROG 02.02Lester J. Peters, Danny Rischin, Brian O’Sullivan et al.|Journal of Clinical Oncology|2010Cited by 806